AM-Pharma SRL
AM-Pharma reported total assets of €1.42m at the end of the 2025 financial year (annual accounts filed with the NBB on 01 Jul 2026).
The score of AM-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +16 % Total assets -1 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AM-Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 01 Jul 2026
- Year ended 31 Dec 2024filed on 21 Aug 2025
- Year ended 31 Dec 2023filed on 22 Aug 2024
- Year ended 31 Dec 2022filed on 04 Jul 2023
- Year ended 31 Dec 2021filed on 31 Aug 2022
AM-Pharma's financial analysis
- Solvency34.7%sector median: 58.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AM-Pharma
AM-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0829.559.341
- VAT number
- BE0829559341
- Peppol
- Registered · 0208:0829559341 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Sep 2010
- Registered office
- 8930 Menen
- Latest accounts
- 2025 · filed on 01 Jul 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
AM-Pharma (SRL) has been based in Menen since 2010, active in: business and other management consultancy activities. For 2025, it reports a net loss of 38,840 € and equity of 493,393 €; its revenue is not published. Its solvency stands at 34.7%, below the median of its sector (58.9%).
Companies similar to AM-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Vimana Business and other management consultancy activities Oudsbergen · balance sheet €1.42m
- Pharmep Business and other management consultancy activities Mons · balance sheet €1.42m
- Embrace IT Business and other management consultancy activities Ghent · balance sheet €1.42m
- FUNELA & Cie Business and other management consultancy activities Donceel · balance sheet €1.42m
- Intertax Holding B.V. Business and other management consultancy activities Lanaken · balance sheet €1.42m
- Gimar Invest Business and other management consultancy activities Ghent · balance sheet €1.42m
- Jeca Management Business and other management consultancy activities Waasmunster · balance sheet €1.43m
- QB-Two Business and other management consultancy activities Sainte-Ode · balance sheet €1.43m
Frequently asked questions about AM-Pharma
What is the revenue of AM-Pharma?
AM-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AM-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0829559341 for AM-Pharma, if the company is VAT-registered. Its company number (CBE) is 0829.559.341.
Where is the registered office of AM-Pharma?
According to the CBE register, the registered office of AM-Pharma is in 8930 Menen.
What is the equity of AM-Pharma?
At the close of the 2025 financial year, the equity of AM-Pharma amounts to 493,393 €, a solvency of 34.7% of total assets.
Who manages AM-Pharma?
The register lists 1 active mandates at AM-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AM-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →